Furthermore, it is well established that BCG enhances tumor-specific immunity by reducing T cell exhaustion and promoting IFN-γ production, thereby augmenting tumor immunogenicity and facilitating apoptosis 32,37. The gene discussed is IFNG; the disease is neoplasm.